Wearable Devices for Patient Monitoring in Long QT Syndrome
Launched by QUEEN MARY UNIVERSITY OF LONDON · Mar 14, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of Long QT Syndrome
- • Aged 18 years or over
- • Phone with iOS version 15 or Android OS 9.0 or higher
- • Able and willing to provide informed consent
- Exclusion Criteria:
- • Unwilling or unable to give consent
- • Ventricular pacing at recruitment
- • Bundle branch block or pre-excitation at baseline
Trial Officials
William J Young, MBBS, PhD
Principal Investigator
Queen Mary University of London and St Bartholomew's Hospital
About Queen Mary University Of London
Queen Mary University of London is a prestigious research-intensive institution recognized for its commitment to advancing medical science and improving health outcomes. As a leading sponsor of clinical trials, the university harnesses its academic excellence and innovative research capabilities to explore groundbreaking treatments and therapies across various medical disciplines. With a focus on collaboration, the institution engages with a diverse network of clinicians, researchers, and industry partners to ensure rigorous study design, ethical conduct, and the translation of research findings into clinical practice. Queen Mary University of London is dedicated to contributing to the global body of knowledge in healthcare through high-quality clinical research that prioritizes patient safety and welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
